Selective exosite inhibition of PAPP-A activity against IGFBP-4

Details for Australian Patent Application No. 2009207645 (hide)

Owner Aarhus Universitet

Inventors Oxvig, Claus; Mikkelsen, Jakob Hauge; Nielsen, Claus Gyrup

Agent Pizzeys

Pub. Number AU-A-2009207645

PCT Pub. Number WO2009/092806

Priority 61/025,545 01.02.08 US; PA 2008 00148 01.02.08 DK; 61/023,631 25.01.08 US

Filing date 23 January 2009

Wipo publication date 30 July 2009

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/092806 Priority application(s): WO2009/092806

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009207646-Device for injecting apportioned doses of liquid drug

2009207644-Humanized anti-human NKG2A monoclonal antibody